Qingdao Kangyuan Pharma

Qingdao Kangyuan Pharmaceutical is a prominent Chinese life sciences company specializing in the development and manufacture of biochemical medicines and active pharmaceutical ingredients (APIs). Established in 1991, the company has built a strong reputation for producing high-quality animal-derived products, including Heparin Sodium, Enoxaparin Sodium, and Pancreatin. Their business model encompasses the full production cycle, from the extraction of raw materials to the formulation of finished pharmaceutical products. The company operates state-of-the-art, GMP-certified facilities in Qingdao, Shandong province. Qingdao Kangyuan serves a global market, providing essential treatments for cardiovascular diseases, hematological disorders, and gastrointestinal conditions.